Latigo Biotherapeutics (NASDAQ:LTGO) Stock Rating Upgraded by Jefferies Financial Group
Latigo Biotherapeutics (NASDAQ:LTGO – Get Free Report) was upgraded by equities research analysts at Jefferies Financial Group to a “strong-buy” rating in a report issued on Tuesday, Zacks reports. Other equities analysts have also recently issued reports about the stock. Wall Street Zen upgraded shares of Latigo Biotherapeutics to a “hold” rating in a research […]
2 Sep 08:08 · The Cerbat Gem